. 2015 Jul 14;5:11764. doi: 10.1038/srep11764

Table 1. Summary of proteomic changes in rd10 mice with or without Adalimumab.

	Protein	C	rd10	rd10 ADA
OXPHOS	NDUFS3	3.1 ± 0.1	1.5 ± 0.2*	2.4 ± 0.2^a
	SDHB	2.1 ± 0.1	1.3 ± 0.1*	2.1 ± 0.2^a
	CORE2	1.4 ± 0.1	0.8 ± 0.1*	1.3 ± 0.1^a
	COX II	2.0 ± 0.1	0.9 ± 0.1*	2.1 ± 0.2^a
	Β-F1	1.6 ± 0.1	0.9 ± 0.1*	1.8 ± 0.1^a
Glycolysis	GADPH	2.0 ± 0.2	1.2 ± 0.1*	2.1 ± 0.2^a
Glycolysis	LDHA	0.70 ± 0.02	0.34 ± 0.04*	0.60 ± 0.05^a
Pentose phosphate pathway	G6PDH	0.48 ± 0.04	0.36 ± 0.05*	0.64 ± 0.07^a
β-oxidation	HADHA	0.34 ± 0.02	0.17 ± 0.01*	0.37 ± 0.03^a
Mitochondrial dynamics	OPA1	1.9 ± 0.1	1.0 ± 0.1*	1.8 ± 0.2^a
Mitochondrial structure	HSP60	0.13 ± 0.01	0.05 ± 0.01*	0.14 ± 0.01^a

Note: Values are expressed as the mean ± SEM of fluorescence intensity (arbitrary units) per ng of total protein of six retinas per group. Values that are significantly different from C57Bl6 (C) are indicated by asterisks *p < 0.05. ‘a’ represent statistical differences (p < 0.05) between rd10 and rd10 ADA (One way ANOVA, Newman-Keuls post-test). ADA: Adalimumab.